{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443987359
| IUPAC_name = 1-Pyridin-4-yl-''N''-(pyridin-4-ylmethyl)methanamine
| image = Gapicomine.png
<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = off market (was used in EU countries)
| routes_of_administration = oral (tablet)
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 68955
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = WWW0P95393
| CAS_number = 1539-39-5
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2103958
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 62178
| smiles = n1ccc(cc1)CNCc2ccncc2
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C12H13N3/c1-5-13-6-2-11(1)9-15-10-12-3-7-14-8-4-12/h1-8,15H,9-10H2
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = AUQQZPGNRKTPSQ-UHFFFAOYSA-N
<!--Chemical data-->
| C=12 | H=13 | N=3
| molecular_weight = 199.25 g/mol
}}

'''Gapicomine''' ([[International Nonproprietary Name|INN]]) is a [[coronary]] [[vasodilator]]. It has been withdrawn from the market in the countries it was used in.<ref>{{cite web |url=http://www.justscience.de/en/drugbase/indexnominum/monograph.html?tx_crondavindexnominum_pi%5Bmonograph_uid%5D=3597&cHash=e51fae0af1 |title=Gapicomine Monograph, The Index Nominum |accessdate=2008-03-31 |format= |work=}}</ref>

Also, gapicomine is a major component in the drug [[Bicordin]].<ref>{{cite web |url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=211061 |title=Bicordin, PubChem |accessdate=2008-03-31 |format= |work=}}</ref>

==History==
Gapicomine was discovered in 1970 by [[Poles|Polish]] [[chemist]] [[Stanisław Biniecki]]. It was first published about in an article of ''The Polish Journal of Medicine and Pharmacy'' describing the derivative drug [[Bicordin]] in 1974.<ref name="PMID4453155">{{cite journal |vauthors=Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E |title=Bicordin--a new drug in the treatment of coronary heart disease. |journal=Mater Med Pol. |volume= 6|issue= 4|pages=298–300 |year=1974 |pmid=4453155 |doi=}}</ref>

==References==
{{reflist}}

{{Vasodilators used in cardiac diseases}}

[[Category:Pyridines]]
[[Category:Vasodilators]]


{{cardiovascular-drug-stub}}